- Home
- SGMT vs RDCM Comparison
SGMT vs RDCM Comparison
Compare SGMT & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- RDCM
- Stock Information
- Founded
- SGMT 2006
- RDCM 1985
- Country
- SGMT United States
- RDCM Israel
- Employees
- SGMT N/A
- RDCM N/A
- Industry
- SGMT
- RDCM Computer peripheral equipment
- Sector
- SGMT
- RDCM Technology
- Exchange
- SGMT Nasdaq
- RDCM Nasdaq
- Market Cap
- SGMT 238.7M
- RDCM 203.7M
- IPO Year
- SGMT 2023
- RDCM 1997
- Fundamental
- Price
- SGMT $7.31
- RDCM $13.80
- Analyst Decision
- SGMT Strong Buy
- RDCM Strong Buy
- Analyst Count
- SGMT 7
- RDCM 1
- Target Price
- SGMT $26.57
- RDCM $18.00
- AVG Volume (30 Days)
- SGMT 480.3K
- RDCM 53.2K
- Earning Date
- SGMT 11-12-2025
- RDCM 11-12-2025
- Dividend Yield
- SGMT N/A
- RDCM N/A
- EPS Growth
- SGMT N/A
- RDCM 79.61
- EPS
- SGMT N/A
- RDCM 0.56
- Revenue
- SGMT N/A
- RDCM $66,334,000.00
- Revenue This Year
- SGMT N/A
- RDCM $18.07
- Revenue Next Year
- SGMT N/A
- RDCM $11.52
- P/E Ratio
- SGMT N/A
- RDCM $24.69
- Revenue Growth
- SGMT N/A
- RDCM 18.18
- 52 Week Low
- SGMT $1.73
- RDCM $9.81
- 52 Week High
- SGMT $11.41
- RDCM $15.98
- Technical
- Relative Strength Index (RSI)
- SGMT 52.06
- RDCM 47.18
- Support Level
- SGMT $7.11
- RDCM $13.76
- Resistance Level
- SGMT $7.66
- RDCM $14.32
- Average True Range (ATR)
- SGMT 0.40
- RDCM 0.49
- MACD
- SGMT 0.11
- RDCM -0.09
- Stochastic Oscillator
- SGMT 76.45
- RDCM 7.74
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.